Global Patent Index - EP 1951277 A2

EP 1951277 A2 20080806 - NATRIURETIC PEPTIDE MODIFIED TRANSFERRIN FUSION PROTEINS

Title (en)

NATRIURETIC PEPTIDE MODIFIED TRANSFERRIN FUSION PROTEINS

Title (de)

MIT NATRIURETISCHEM PEPTID MODIFIZIERTE TRANSFERRIN-FUSIONSPROTEINE

Title (fr)

PROTEINES HYBRIDES DE TRANSFERRINE MODIFIEES PAR DES PEPTIDES NATRIURETIQUES

Publication

EP 1951277 A2 20080806 (EN)

Application

EP 06825957 A 20061016

Priority

  • US 2006040207 W 20061016
  • US 72619805 P 20051014

Abstract (en)

[origin: WO2007047504A2] Fusion proteins of transferrin and natriuretic peptides with increased serum half-life or serum stability are disclosed. Preferred fusion proteins include those modified so that the transferrin moiety exhibits no or reduced glycosylation, binding to iron and/or binding to the transferrin receptor.

IPC 8 full level

A61K 38/00 (2006.01)

CPC (source: EP)

A61K 47/644 (2017.07); A61P 3/12 (2017.12); A61P 9/00 (2017.12); A61P 9/04 (2017.12); A61P 9/12 (2017.12); C07K 14/58 (2013.01); C07K 14/79 (2013.01); A61K 38/00 (2013.01); C07K 2319/31 (2013.01)

Citation (search report)

See references of WO 2007047504A2

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

DOCDB simple family (publication)

WO 2007047504 A2 20070426; WO 2007047504 A3 20070614; CA 2625600 A1 20070426; EP 1951277 A2 20080806; JP 2009511060 A 20090319

DOCDB simple family (application)

US 2006040207 W 20061016; CA 2625600 A 20061016; EP 06825957 A 20061016; JP 2008535740 A 20061016